GoodRx Holdings, Inc. GDRX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Other revenue | $3.69M-11.4% | $4.16M-10.2% | $4.64M+1.7% | $4.56M+4.1% | $4.38M-9.3% | |
| Pharma Direct revenue | $52.23M— | —— | $43.37M+24.0% | $34.98M+22.1% | $28.65M+2.0% | |
| Prescription transactions revenue | $113.69M-8.8% | $124.72M-2.0% | $127.29M-11.0% | $143.06M-3.9% | $148.92M+2.7% | |
| Subscription revenue | $24.39M+13.3% | $21.52M+3.9% | $20.72M+1.3% | $20.46M-2.6% | $21.02M+1.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does GoodRx Holdings, Inc. break its business down?
- GoodRx Holdings, Inc. (GDRX) reports revenue by product across 4 parts — Other revenue, Pharma Direct revenue, Prescription transactions revenue and Subscription revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does GoodRx Holdings, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in GoodRx Holdings, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
